Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareStart™ G6PD deficiency screening test (Access Bio, New Jersey, USA) by comparing its performance to quantitative G6PD enzyme activity using a standardized spectrophotometric method ('gold standard'). Blood samples (n = 903) were collected from Cambodian adults living in Pailin province, western Cambodia. G6PD enzyme activities ranged from 0 to 20.5 U/g Hb (median 12.0 U/g Hg). Based on a normal haemoglobin concentration and wild-type G6PD gene, the normal values of G6PD enzymatic activity for this population was 3.6 to 20.5 U/g Hg (95(th) percentiles from 5.5 to 17.2 U/g Hg). Ninety-seven subjects (10.7%) had <3.6 U/g Hg and were classified as G6PD deficient. Prevalence of deficiency was 15.0% (64/425) among men and 6.9% (33/478) among women. Genotype was analyzed in 66 G6PD-deficient subjects and 63 of these exhibited findings consistent with Viangchang genotype. The sensitivity and specificity of the CareStart™ G6PD deficiency screening test was 0.68 and 1.0, respectively. Its detection threshold was <2.7 U/g Hg, well within the range of moderate and severe enzyme deficiencies. Thirteen subjects (1.4%, 12 males and 1 female) with G6PD enzyme activities <2 U/g Hg were falsely classified as "normal" by RDT. This experimental RDT test here evaluated outside of the laboratory for the first time shows real promise, but safe application of it will require lower rates of falsely "normal" results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FST and recently introduced, point-of-care, qualitative rapid diagnostic tests (RDTs) can reliably detect G6PD activities of < 30% activity but they have not been fully validated for detecting heterozygous females having ≥ 30% of normal activity and fail to detect G6PDd with increasing G6PD activity[18,19,20].”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 1×
“Therefore, primaquine remains a vitally important tool to block the transmission of parasites, especially in areas like Cambodia, where artemisinin resistant parasites are well documented [4,5,6].”
BackgroundSelf-citation
Cited by
Howes, R. E., Piel, F. B., Patil, A. P., Nyangiri, O. A., Gething, P. W., Dewi, M., Hogg, M. M., Battle, K. E., Padilla, C. D., Baird, J. K., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001339 · Cited by 562
Self-citationTargeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination
Sturrock, H. J. W., Hsiang, M. S., Cohen, J. M., Smith, D. L., Greenhouse, B., Bousema, T., & Gosling, R. D. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001467 · Cited by 341
“While tests for G6PD deficiency are available, more sensitive and inexpensive point of care tests for G6PD deficiency are needed [61].”
BackgroundRobinson, L. J., Wampfler, R., Betuela, I., Karl, S., White, M. T., Li Wai Suen, C. S. N., Hofmann, N. E., Kinboro, B., Waltmann, A., Brewster, J., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001891 · Cited by 276
Primaquine: the risks and the benefits
Ashley, E. A., Recht, J., & White, N. J. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-418 · Cited by 252
Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
Bancone, G., Chu, C. S., Somsakchaicharoen, R., Chowwiwat, N., Parker, D. M., Charunwatthana, P., White, N. J., & Nosten, F. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116063 · Cited by 99
“Not surprisingly, the molecular heterogeneity of the G6PD gene found in this area is comparable to most of other places where this has been investigated (Cambodia, [5]; West Africa, [33] and [34]; China, [35]).”
BackgroundMethodResult
Metadata
- Authors
- Kim, S., Nguon, C., Guillard, B., Duong, S., Chy, S., Sum, S., Nhem, S., Bouchier, C., Tichit, M., Christophel, E., Taylor, W. R. J., Baird, J. K., & Menard, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-02
- Volume
- 6
- Issue
- 12
- Pages
- e28357
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2140498466
- Cited by
- 124
- References
- 1
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.